Leukocyte Count Is a Modulating Factor for the Mortality Benefit of Bivalirudin in ST-Segment–Elevation Acute Myocardial Infarction

Title
Leukocyte Count Is a Modulating Factor for the Mortality Benefit of Bivalirudin in ST-Segment–Elevation Acute Myocardial Infarction
Authors
Keywords
-
Journal
Circulation-Cardiovascular Interventions
Volume 6, Issue 5, Pages 518-526
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-10-02
DOI
10.1161/circinterventions.113.000592

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started